NeoplasmsRESETNCT07727876
Ready for Safe Cancer Treatment (RESET): A Comprehensive Perioperative Program for Surgical Oncology
A study testing RESET multimodal perioperative care pathway and Standard perioperative care in people with Neoplasms and Frailty, run by Regional Specialist Hospital in Wroclaw at 2 sites in Poland.
Trial summary
The goal of this randomized controlled clinical trial is to evaluate whether the Ready for Safe Cancer Treatment (RESET) program improves perioperative care and supports safe hospital discharge in two surgical populations: adult patients undergoing planned oncological surgery and patients aged 70 years or older… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Neoplasms, Frailty, Surgical Procedures, Operative
- What is being tested?
- RESET multimodal perioperative care pathway and Standard perioperative care
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 12,800 participants
- Where
- 2 sitesPoland
- Study dates
- 16 Feb 2026to 31 Jul 2031
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age ≥ 18 years
- Qualification for admission to surgical departments with an ICD10 diagnosis for radical cancer surgery
- Preliminary qualification for one of the procedures listed in Section II.B.23
- Informed consent to participate in the study
- Informed consent to participate in the study
- Age ≥ 70 years
- All consecutive patients referred for planned non-oncological surgical procedures, not solely diagnostic, performed under general anesthesia
Who cannot join
- Age < 18 years
- Qualification for admission to surgical departments with an ICD10 diagnosis for diagnostic procedures to identify cancer
- Pregnancy or breastfeeding
- NON-ONCOLOGY GROUP
- Diagnosis of cancer
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Poland2 sites, 2 recruiting
- Recruiting
4th Military Clinical Hospital in Wroclaw
Wroclaw, Lower Silesian Voivodeship, 50-981
Anna Skotny, PhD, (+48) 71 727 41 46, cwbk@4wsk.pl
- Recruiting
Regional Specialist Hospital in Wrocław
Wroclaw, Lower Silesian Voivodeship, 51-124
Natalia Jędruchniewicz, PhD, +48713270538, natalia.jedruchniewicz@wssk.wroc.pl
Małgorzata Wierzbicka, Professor
About this study
Official title: Comprehensive Tool to Improve the Quality and Optimize Hospitalization of Oncological Surgery Patients Implemented for Timely, Safe Discharge From Hospital - Ready for Safe Cancer Treatment RESET, Consisting of a Standardized Sequence of Processes -From Prehabilitation, Therapeutic Team/Patient/Family Advanced Communication, Early Rehabilitation Protocol, Followed by Individual Transitional Care Program, Dedicated to Oncology Network Hospitals
The goal of this randomized controlled clinical trial is to evaluate whether the Ready for Safe Cancer Treatment (RESET) program improves perioperative care and supports safe hospital discharge in two surgical populations: adult patients undergoing planned oncological surgery and patients aged 70 years or older undergoing planned non-oncological surgery under general anesthesia.
RESET is a comprehensive, multidisciplinary care pathway that combines prehabilitation, standardized perioperative care, enhanced recovery, and individualized transitional care after discharge.
Read more
The main questions it aims to answer are:
Does the RESET program reduce postoperative complications, prolonged hospitalizations, and unplanned rehospitalizations after oncological and non-oncological surgery?
Does the RESET program improve patients' overall health status, physical function, quality of life, perioperative safety, and recovery?
Does implementation of RESET improve the organization and efficiency of hospital care while reducing healthcare resource utilization and costs?
Researchers will compare patients receiving the RESET program with patients receiving standard perioperative care to determine whether the comprehensive intervention leads to improved clinical, organizational, and patient-reported outcomes.
Participants assigned to the RESET intervention will:
undergo a comprehensive multidisciplinary prehabilitation assessment performed by a physician, physiotherapist, dietitian, psychologist, clinical pharmacist, nurse, and study coordinator;
receive an individualized prehabilitation program that may include physical exercise, nutritional support, psychological support, medication optimization, and patient education before surgery;
use a dedicated RESET mobile application to communicate with the multidisciplinary prehabilitation team, ask questions, receive individualized recommendations and information, follow the schedule of visits and planned activities, and support adherence to the intervention;
undergo reassessment of their health status, needs, and implementation of recommendations on the day of hospital admission, allowing barriers to be identified and the perioperative care plan to be optimized;
receive standardized in-hospital perioperative care incorporating Enhanced Recovery After Surgery principles, the SAFER Patient Flow Bundle, the Red2Green methodology, medication review by a clinical pharmacist, and coordinated multidisciplinary care;
receive an individualized transitional care plan after discharge, including follow-up support and monitoring for complications and rehospitalization.
Participants in the control group will receive standard perioperative care according to routine clinical practice at the participating hospitals.
The study will evaluate clinical outcomes, including postoperative complications, prolonged hospitalization, rehospitalization, recovery, overall health status, physical function, and quality of life. It will also evaluate patient satisfaction, adherence to the RESET pathway, organizational effectiveness, and costs associated with implementation of RESET.
The results are expected to support the development of an evidence-based and scalable perioperative care model that can be used in oncological surgery and in older patients undergoing major non-oncological surgery.
Read the detailed description
RESET is a prospective, two-center, two-arm, parallel-group randomized controlled study evaluating a comprehensive perioperative care pathway in two surgical populations.
The oncology population includes adults aged 18 years or older who are qualified for planned oncological surgery that is not solely diagnostic. The non-oncology population includes patients aged 70 years or older who are qualified for planned non-oncological surgery, not solely diagnostic, performed under general anesthesia.
After providing written informed consent and meeting the eligibility criteria, participants from both populations will be randomly assigned in a 9:1 ratio to either the RESET intervention arm or the standard-care control arm. Participants in both populations follow the same general study pathway, with individual procedures and recommendations adapted to their clinical condition, age, type of surgery, functional capacity, and identified needs.
The RESET intervention covers the complete perioperative pathway, beginning with preoperative preparation and continuing through hospitalization, postoperative recovery, discharge planning, and follow-up. The program is organized into four interconnected modules: prehabilitation, hospitalization and discharge planning, postoperative recovery, and transitional care. RESET is evaluated as an integrated, multicomponent care pathway rather than as a set of independently tested interventions.
Module I: Prehabilitation
The first multidisciplinary prehabilitation visit is scheduled approximately 21 ± 7 days before surgery. Participants undergo a comprehensive assessment of their clinical condition, perioperative risk, physical function, nutritional status, psychological status, medication use, comorbidities, and individual support needs.
The assessment is performed by members of the multidisciplinary team, including a physician, physiotherapist, dietitian, psychologist, clinical pharmacist, nurse, and study coordinator. Protocol-defined medical scales, questionnaires, laboratory parameters, physical function tests, and other assessments are used in accordance with the study schedule.
Based on the assessment results, each participant receives an individualized prehabilitation plan. Depending on the needs identified, the plan may include recommendations concerning physical activity and exercise, nutrition, psychological support, medication optimization, management of modifiable risk factors, and education related to the planned surgery and postoperative recovery.
Physical activity is monitored using an activity-monitoring wristband. A dedicated RESET mobile application is used to provide participants with individualized recommendations, general information, schedules of visits and planned activities, and access to communication with the multidisciplinary prehabilitation team. The wristband, application, and follow-up assessments are used to monitor implementation of the prehabilitation recommendations.
When additional specialist input is required, consultations may be organized through Stochastic Organizational Support Network Planning. The number of interventions conducted within this system and waiting times for specialist consultations will be evaluated and compared with average waiting times within the standard National Health Fund system.
A second prehabilitation assessment is conducted on the day of planned hospital admission. The study team evaluates changes in the participant's health status, current medical, nutritional, physical, psychological, and medication-related needs, and implementation of the recommendations provided during the prehabilitation period. Identified barriers and new needs are considered when reviewing the perioperative care plan.
Module II: Hospitalization and discharge planning
During hospitalization, participants receive coordinated multidisciplinary perioperative care. Structured communication is maintained among the therapeutic team, the participant, and, where appropriate and with the participant's involvement, the participant's family or caregiver.
The RESET pathway incorporates Enhanced Recovery After Surgery principles, the SAFER Patient Flow Bundle, the Red2Green methodology, clinical pharmacist involvement, and coordinated assessment of clinical and organizational factors that may affect the course of hospitalization and readiness for discharge.
The treatment schedule, planned surgery, postoperative care, anticipated discharge, and current participant needs are reviewed during hospitalization. Discharge planning begins early and is updated according to the participant's clinical condition and recovery.
Module III: Postoperative recovery
Following surgery, the study team assesses the postoperative course and adapts further care to the participant's clinical condition. Monitoring includes postoperative complications, pain, wound healing, physical recovery, nutritional needs, and readiness for discharge.
Postoperative complications are evaluated according to the study protocol. Early mobilization and rehabilitation are introduced when clinically possible and are adjusted to the participant's previous activity level, current functional capacity, and postoperative condition.
Module IV: Transitional care and follow-up
Before discharge, the participant receives individualized recommendations concerning further treatment, medication use, nutrition, physical activity, rehabilitation, follow-up care, and symptoms requiring contact with healthcare professionals.
The transitional care component is intended to support continuity of care after discharge and the early identification of complications or other needs. Information concerning the course of recovery, postoperative complications, use of healthcare services, and hospital readmissions is collected during follow-up.
The final follow-up assessment is planned approximately 30 days after surgery in accordance with the study schedule. Depending on the applicable protocol procedures and the participant's clinical and organizational circumstances, follow-up may include an on-site visit or telephone contact. Hospital readmissions are assessed during the 30-day period after discharge.
Control arm
Participants assigned to the control arm receive standard perioperative care according to routine clinical practice at the participating hospitals. This includes routine surgical and anesthetic qualification, clinically indicated preoperative tests and consultations, standard inpatient surgical and postoperative care, discharge recommendations, and routine follow-up.
Control-arm participants do not receive the coordinated multidisciplinary RESET pathway, the individualized RESET prehabilitation program, or the RESET transitional care program.
Outcome assessment
The primary endpoints are prolonged hospitalization, hospital readmission, and postoperative complications. Prolonged hospitalization is defined in the study protocol as an index hospital stay lasting at least 14 days. Hospital readmission is evaluated during the 30-day period after discharge.
The secondary endpoints are length of hospital stay, overall health status, patient satisfaction, compliance with the prehabilitation protocol, effectiveness of Stochastic Organizational Support Network Planning, and costs associated with RESET.
Length of hospital stay is measured as the number of days from admission to discharge. In accordance with the predefined secondary endpoint, the comparative assessment of length of stay includes cases without postoperative complications.
Overall health status is evaluated using protocol-defined medical scales, blood parameters, physical function measures, and allostatic load measures. Assessments are conducted before and after the preoperative intervention and during post-discharge follow-up according to the study protocol.
Patient satisfaction is assessed using a dedicated questionnaire. Compliance is monitored using the activity-monitoring wristband, the mobile application, and follow-up assessments.
The effectiveness of Stochastic Organizational Support Network Planning is evaluated using the number of interventions conducted within the system and participant waiting times for specialist consultations, compared with average waiting times in the standard National Health Fund system.
Costs associated with RESET are evaluated through analysis of the costs of prehabilitation, hospitalization, rehabilitation, postoperative follow-up visits, prolonged hospitalization, and rehospitalization, together with financial effectiveness indicators. Costs are compared between the RESET intervention arm and the standard-care control arm.
- Conditions
- Neoplasms, Frailty, Surgical Procedures, Operative
- Being tested
- RESET multimodal perioperative care pathway, Standard perioperative care
- Keywords
- prehabilitation, perioperative care, surgical oncology, enhanced recovery after surgery, transitional care, hospital discharge, multidisciplinary care, postoperative complications, rehospitalization, prolonged hospitalization, patient flow, frailty, geriatric surgery, cancer surgery, supportive care
- Medical subject headings
- Neoplasms, Frailty, Postoperative Complications
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
RESET multimodal perioperative care pathwayOther
RESET is a standardized, individualized, multidisciplinary perioperative care pathway delivered from approximately 21±7 days before surgery through 30-day follow-up. It includes: (1) preoperative assessment and personalized prehabilitation addressing nutrition, physical activity, psychological support, and medication optimization; (2) care coordination and communication with the prehabilitation team, supported by the RESET mobile application; (3) reassessment on hospital admission and coordinated perioperative planning; (4) enhanced recovery during hospitalization, including early mobilization, nutritional support, pain management, the SAFER Patient Flow Bundle, and Red-to-Green review; and (5) individualized discharge planning and transitional care. Components are tailored to the participant's clinical status, functional capacity, nutritional and psychological needs, comorbidities, and planned surgery.
Standard perioperative careOther
Participants receive standard perioperative care according to routine practice at the participating hospital. This includes usual surgical and anesthetic qualification, preoperative tests and consultations when clinically indicated, routine inpatient surgical and postoperative care, discharge instructions, and standard follow-up. Participants do not receive the coordinated multidisciplinary RESET pathway or individualized RESET recommendations. Protocol-defined assessments and activity monitoring are performed in both study arms for research purposes and are not components of the comparator intervention.
| Study group | Role | What they receive |
|---|---|---|
| RESET Intervention | Experimental | Participants receive the comprehensive RESET perioperative care pathway, including individualized multidisciplinary prehabilitation, structured perioperative management, enhanced recovery principles, coordinated discharge planning, transitional care, and follow-up using the RESET digital platform. The intervention is tailored to individual patient needs while following standardized study procedures. Both oncology and elderly (non-oncology) participants may be allocated to this arm. Receives: Other: RESET multimodal perioperative care pathway |
| Standard Perioperative Care | Active comparator | Participants receive standard perioperative care according to routine institutional practice without the coordinated RESET programme. Standard care may include selected supportive interventions if clinically indicated but does not include the structured multidisciplinary RESET pathway. Both oncology and elderly (non-oncology) participants may be allocated to this arm. Receives: Other: Standard perioperative care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of participants with prolonged index hospitalization lasting 14 calendar days or longer
Prolonged index hospitalization is defined as a hospital stay lasting 14 calendar days or longer, calculated from admission for the index surgical hospitalization to hospital discharge. The outcome will be reported as the number and percentage of participants meeting this definition in each study arm.
Measured: From the date of index hospital admission until the date of hospital discharge; prolonged hospitalization is determined when the index hospital stay reaches at least 14 calendar days, assessed up to 90 days after admission
Number of participants with an unplanned hospital readmission within 30 days after index hospital discharge
An unplanned hospital readmission is defined as an unplanned admission to the same or another hospital within 30 days after discharge from the index hospitalization. Readmissions will be identified using hospital electronic health records, hospital information systems, and participant follow-up interviews. The outcome will be reported as the number and percentage of participants with at least one unplanned readmission.
Measured: 30 days after index hospital discharge
Participants with at least one postoperative complication within 30 days after index surgery
Postoperative complications occurring after the index surgical procedure will be identified and graded according to the Clavien-Dindo classification. The outcome will be reported as the number and percentage of participants with at least one Clavien-Dindo grade I-V complication within 30 days after index surgery. For participants with multiple postoperative complications, the highest Clavien-Dindo grade observed during this period will also be recorded.
Measured: From completion of index surgery through postoperative day 30
Secondary outcomes (6)
Length of index hospital stay in calendar days
Length of index hospital stay will be measured in calendar days from admission for the index surgical hospitalization to hospital discharge. The primary analysis of this secondary outcome will include all randomized participants, including participants who experience postoperative complications. Length of stay will be compared between the RESET intervention arm and the standard-care control arm.
Measured: From the date of index hospital admission until the date of hospital discharge, assessed up to 90 days after admission
Change in overall health status
Overall health status will be assessed as a multidomain secondary outcome using protocol-defined measures: patient-reported and clinical scale scores, including SF-36 and HADS; laboratory parameters and measures of allostatic load; physical function tests, including the 6-minute walk test, handgrip strength measured by dynamometry, FEV1, and the sit-to-stand test; and anthropometric and nutritional measures, including BMI, waist-to-hip ratio, and body composition assessed by bioelectrical impedance analysis. Each component will be recorded and analyzed separately using its validated score or original measurement unit. Changes from baseline to the post-prehabilitation assessment at index hospital admission and to the follow-up visit 30 ± 5 days after discharge will be calculated and compared between the RESET intervention and standard-care control arms. Results will be interpreted according to the scoring rules, units, and direction of change applicable to each measure.
Measured: Baseline at 21 ± 7 days before surgery, at index hospital admission before surgery following the preoperative intervention, and at 30 ± 5 days after hospital discharge
Patient satisfaction
Patient satisfaction will be assessed using the dedicated study-specific patient satisfaction questionnaire. The questionnaire will evaluate the participant's experience with the prehabilitation program and the care provided within the RESET pathway.
Measured: At the summary prehabilitation visit on the day 1 of hospital admission
Compliance with the prehabilitation protocol
Compliance with the individualized prehabilitation protocol will be monitored using data collected from the activity-monitoring wristband, the dedicated mobile application, and follow-up assessments. Compliance data will be used to evaluate the extent to which participants followed the prehabilitation recommendations provided by the multidisciplinary team.
Measured: From the baseline prehabilitation visit, scheduled 21 ± 7 days before surgery, through hospital admission for surgery
Effectiveness of Stochastic Organizational Support Network Planning
The effectiveness of Stochastic Organizational Support Network Planning (SOSNP) will be evaluated based on the number of interventions performed within the SOSNP and participant waiting times for the required specialist consultations. Waiting times within the SOSNP will be compared with the average waiting times for corresponding specialist consultations in the standard Polish National Health Fund system.
Measured: From the baseline prehabilitation visit, scheduled 21 ± 7 days before surgery, through hospital admission for surgery
Direct healthcare costs
Costs associated with RESET will be evaluated based on the costs of prehabilitation, index hospitalization, rehabilitation, postoperative follow-up visits, prolonged hospitalization, and hospital readmission. Financial effectiveness indicators will also be assessed. Costs will be compared between participants assigned to the RESET intervention arm and participants assigned to the standard-care control arm.
Measured: From the baseline prehabilitation visit through 30 days after discharge from the index hospitalization
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jul 2026
- Study start16 Feb 2026
- Primary completion16 May 2030 (estimated)
- Study completion31 Jul 2031 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for NeoplasmsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This is a prospective, multicenter, parallel-group randomized controlled trial evaluating the RESET programme versus standard perioperative care. Participants are randomized in a 9:1 ratio to receive either the multidisciplinary RESET intervention or routine care according to local clinical practice. The study includes two predefined patient populations: patients undergoing oncological surgery and elderly patients undergoing major non-oncological surgery. Both populations are randomized using the same study design and intervention strategy, with predefined subgroup analyses planned for each population. Randomization is performed centrally using a web-based dynamic allocation (biased-coin) procedure. Participants remain in their assigned study arm throughout the study without crossover.
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 12,800 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Regional Specialist Hospital in Wroclaw
- Sponsor type
- University, hospital or other
- Collaborators
- Łukasiewicz Research Network - PORT Polish Center for Technology Development, 4th Military Clinical Hospital with Polyclinic, Poland
- Responsible party
- Sponsor
- Investigators
- Małgorzata Wierzbicka, Professor, Principal investigator, Regional Specialist Hospital in Wroclaw
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07727876
- Sponsor's protocol ID
- 2024/ABM/02/00051
- Other IDs
- 2024/ABM/02/00051
- Acronym
- RESET
- Status last verified
- Jul 2026
- First submitted
- 17 Jul 2026
- Last updated
- 27 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: De-identified individual participant data underlying the results reported in study publications will be made available upon reasonable request to the Principal Investigator. Shared data may include the participant-level analysis dataset and the associated data dictionary. Supporting materials may include the full study protocol and statistical code. Data sharing will be subject to compliance with participant consent, applicable data-protection requirements, institutional requirements, and approval of the proposed use by the Sponsor and Principal Investigator.
Publications
Wierzbicka M, Kiszka M, Barnas S, Jeziorny M, Zajac B, Dwornikowska-Dabrowska M, Jedruchniewicz N. The Ready for Safe Cancer Treatment (RESET) tool: enhancing quality and optimizing timely and safe discharge with transitional care adjustments for Head and Neck Cancer patients. Otolaryngol Pol. 2025 Mar 14;79(3):1-7. doi: 10.5604/01.3001.0055.0006.
PubMed 40084835
Study at a glance
From the registry record, last updated by the sponsor on 27 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comprehensive Tool to Improve the Quality and Optimize Hospitalization of Oncological Surgery Patients Implemented for Timely, Safe Discharge From Hospital - Ready for Safe Cancer Treatment RESET, Consisting of a Standardized Sequence of Processes -From Prehabilitation, Therapeutic Team/Patient/Family Advanced Communication, Early Rehabilitation Protocol, Followed by Individual Transitional Care Program, Dedicated to Oncology Network Hospitals
- ClinicalTrials.gov ID
- NCT07727876
- Acronym / sponsor ID
- RESET / 2024/ABM/02/00051
- Conditions
- Neoplasms, Frailty, Surgical Procedures, Operative
- Keywords
- prehabilitation, perioperative care, surgical oncology, enhanced recovery after surgery, transitional care, hospital discharge, multidisciplinary care, postoperative complications
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 12,800 participants (estimated)
- Lead sponsor
- Regional Specialist Hospital in WroclawUniversity, hospital or other
- Collaborators
- Łukasiewicz Research Network - PORT Polish Center for Technology Development, 4th Military Clinical Hospital with Polyclinic, Poland
- Study start
- 16 Feb 2026 (actual)
- Primary completion
- 16 May 2030 (estimated)
- Study completion
- 31 Jul 2031 (estimated)
- First posted
- 27 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this randomized controlled clinical trial is to evaluate whether the Ready for Safe Cancer Treatment (RESET) program improves perioperative care and supports safe hospital discharge in two surgical populations: adult patients undergoing planned oncological surgery and patients aged 70 years or older undergoing planned non-oncological surgery under general anesthesia.
RESET is a comprehensive, multidisciplinary care pathway that combines prehabilitation, standardized perioperative care, enhanced recovery, and individualized transitional care after discharge.
The main questions it aims to answer are:
Does the RESET program reduce postoperative complications, prolonged hospitalizations, and unplanned rehospitalizations after oncological and non-oncological surgery?
Does the RESET program improve patients' overall health status, physical function, quality of life, perioperative safety, and recovery?
Does implementation of RESET improve the organization and efficiency of hospital care while reducing healthcare resource utilization and costs?
Researchers will compare patients receiving the RESET program with patients receiving standard perioperative care to determine whether the comprehensive intervention leads to improved clinical, organizational, and patient-reported outcomes.
Participants assigned to the RESET intervention will:
undergo a comprehensive multidisciplinary prehabilitation assessment performed by a physician, physiotherapist, dietitian, psychologist, clinical pharmacist, nurse, and study coordinator;
receive an individualized prehabilitation program that may include physical exercise, nutritional support, psychological support, medication optimization, and patient education before surgery;
use a dedicated RESET mobile application to communicate with the multidisciplinary prehabilitation team, ask questions, receive individualized recommendations and information, follow the schedule of visits and planned activities, and support adherence to the intervention;
undergo reassessment of their health status, needs, and implementation of recommendations on the day of hospital admission, allowing barriers to be identified and the perioperative care plan to be optimized;
receive standardized in-hospital perioperative care incorporating Enhanced Recovery After Surgery principles, the SAFER Patient Flow Bundle, the Red2Green methodology, medication review by a clinical pharmacist, and coordinated multidisciplinary care;
receive an individualized transitional care plan after discharge, including follow-up support and monitoring for complications and rehospitalization.
Participants in the control group will receive standard perioperative care according to routine clinical practice at the participating hospitals.
The study will evaluate clinical outcomes, including postoperative complications, prolonged hospitalization, rehospitalization, recovery, overall health status, physical function, and quality of life. It will also evaluate patient satisfaction, adherence to the RESET pathway, organizational effectiveness, and costs associated with implementation of RESET.
The results are expected to support the development of an evidence-based and scalable perioperative care model that can be used in oncological surgery and in older patients undergoing major non-oncological surgery.
Detailed description
RESET is a prospective, two-center, two-arm, parallel-group randomized controlled study evaluating a comprehensive perioperative care pathway in two surgical populations.
The oncology population includes adults aged 18 years or older who are qualified for planned oncological surgery that is not solely diagnostic. The non-oncology population includes patients aged 70 years or older who are qualified for planned non-oncological surgery, not solely diagnostic, performed under general anesthesia.
After providing written informed consent and meeting the eligibility criteria, participants from both populations will be randomly assigned in a 9:1 ratio to either the RESET intervention arm or the standard-care control arm. Participants in both populations follow the same general study pathway, with individual procedures and recommendations adapted to their clinical condition, age, type of surgery, functional capacity, and identified needs.
The RESET intervention covers the complete perioperative pathway, beginning with preoperative preparation and continuing through hospitalization, postoperative recovery, discharge planning, and follow-up. The program is organized into four interconnected modules: prehabilitation, hospitalization and discharge planning, postoperative recovery, and transitional care. RESET is evaluated as an integrated, multicomponent care pathway rather than as a set of independently tested interventions.
Module I: Prehabilitation
The first multidisciplinary prehabilitation visit is scheduled approximately 21 ± 7 days before surgery. Participants undergo a comprehensive assessment of their clinical condition, perioperative risk, physical function, nutritional status, psychological status, medication use, comorbidities, and individual support needs.
The assessment is performed by members of the multidisciplinary team, including a physician, physiotherapist, dietitian, psychologist, clinical pharmacist, nurse, and study coordinator. Protocol-defined medical scales, questionnaires, laboratory parameters, physical function tests, and other assessments are used in accordance with the study schedule.
Based on the assessment results, each participant receives an individualized prehabilitation plan. Depending on the needs identified, the plan may include recommendations concerning physical activity and exercise, nutrition, psychological support, medication optimization, management of modifiable risk factors, and education related to the planned surgery and postoperative recovery.
Physical activity is monitored using an activity-monitoring wristband. A dedicated RESET mobile application is used to provide participants with individualized recommendations, general information, schedules of visits and planned activities, and access to communication with the multidisciplinary prehabilitation team. The wristband, application, and follow-up assessments are used to monitor implementation of the prehabilitation recommendations.
When additional specialist input is required, consultations may be organized through Stochastic Organizational Support Network Planning. The number of interventions conducted within this system and waiting times for specialist consultations will be evaluated and compared with average waiting times within the standard National Health Fund system.
A second prehabilitation assessment is conducted on the day of planned hospital admission. The study team evaluates changes in the participant's health status, current medical, nutritional, physical, psychological, and medication-related needs, and implementation of the recommendations provided during the prehabilitation period. Identified barriers and new needs are considered when reviewing the perioperative care plan.
Module II: Hospitalization and discharge planning
During hospitalization, participants receive coordinated multidisciplinary perioperative care. Structured communication is maintained among the therapeutic team, the participant, and, where appropriate and with the participant's involvement, the participant's family or caregiver.
The RESET pathway incorporates Enhanced Recovery After Surgery principles, the SAFER Patient Flow Bundle, the Red2Green methodology, clinical pharmacist involvement, and coordinated assessment of clinical and organizational factors that may affect the course of hospitalization and readiness for discharge.
The treatment schedule, planned surgery, postoperative care, anticipated discharge, and current participant needs are reviewed during hospitalization. Discharge planning begins early and is updated according to the participant's clinical condition and recovery.
Module III: Postoperative recovery
Following surgery, the study team assesses the postoperative course and adapts further care to the participant's clinical condition. Monitoring includes postoperative complications, pain, wound healing, physical recovery, nutritional needs, and readiness for discharge.
Postoperative complications are evaluated according to the study protocol. Early mobilization and rehabilitation are introduced when clinically possible and are adjusted to the participant's previous activity level, current functional capacity, and postoperative condition.
Module IV: Transitional care and follow-up
Before discharge, the participant receives individualized recommendations concerning further treatment, medication use, nutrition, physical activity, rehabilitation, follow-up care, and symptoms requiring contact with healthcare professionals.
The transitional care component is intended to support continuity of care after discharge and the early identification of complications or other needs. Information concerning the course of recovery, postoperative complications, use of healthcare services, and hospital readmissions is collected during follow-up.
The final follow-up assessment is planned approximately 30 days after surgery in accordance with the study schedule. Depending on the applicable protocol procedures and the participant's clinical and organizational circumstances, follow-up may include an on-site visit or telephone contact. Hospital readmissions are assessed during the 30-day period after discharge.
Control arm
Participants assigned to the control arm receive standard perioperative care according to routine clinical practice at the participating hospitals. This includes routine surgical and anesthetic qualification, clinically indicated preoperative tests and consultations, standard inpatient surgical and postoperative care, discharge recommendations, and routine follow-up.
Control-arm participants do not receive the coordinated multidisciplinary RESET pathway, the individualized RESET prehabilitation program, or the RESET transitional care program.
Outcome assessment
The primary endpoints are prolonged hospitalization, hospital readmission, and postoperative complications. Prolonged hospitalization is defined in the study protocol as an index hospital stay lasting at least 14 days. Hospital readmission is evaluated during the 30-day period after discharge.
The secondary endpoints are length of hospital stay, overall health status, patient satisfaction, compliance with the prehabilitation protocol, effectiveness of Stochastic Organizational Support Network Planning, and costs associated with RESET.
Length of hospital stay is measured as the number of days from admission to discharge. In accordance with the predefined secondary endpoint, the comparative assessment of length of stay includes cases without postoperative complications.
Overall health status is evaluated using protocol-defined medical scales, blood parameters, physical function measures, and allostatic load measures. Assessments are conducted before and after the preoperative intervention and during post-discharge follow-up according to the study protocol.
Patient satisfaction is assessed using a dedicated questionnaire. Compliance is monitored using the activity-monitoring wristband, the mobile application, and follow-up assessments.
The effectiveness of Stochastic Organizational Support Network Planning is evaluated using the number of interventions conducted within the system and participant waiting times for specialist consultations, compared with average waiting times in the standard National Health Fund system.
Costs associated with RESET are evaluated through analysis of the costs of prehabilitation, hospitalization, rehabilitation, postoperative follow-up visits, prolonged hospitalization, and rehospitalization, together with financial effectiveness indicators. Costs are compared between the RESET intervention arm and the standard-care control arm.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
- Model description
- This is a prospective, multicenter, parallel-group randomized controlled trial evaluating the RESET programme versus standard perioperative care. Participants are randomized in a 9:1 ratio to receive either the multidisciplinary RESET intervention or routine care according to local clinical practice. The study includes two predefined patient populations: patients undergoing oncological surgery and elderly patients undergoing major non-oncological surgery. Both populations are randomized using the same study design and intervention strategy, with predefined subgroup analyses planned for each population. Randomization is performed centrally using a web-based dynamic allocation (biased-coin) procedure. Participants remain in their assigned study arm throughout the study without crossover.
| Arm | Type | Receives |
|---|---|---|
| RESET Intervention | Experimental | Other: RESET multimodal perioperative care pathwayParticipants receive the comprehensive RESET perioperative care pathway, including individualized multidisciplinary prehabilitation, structured perioperative management, enhanced recovery principles, coordinated discharge planning, transitional care, and follow-up using the RESET digital platform. The intervention is tailored to individual patient needs while following standardized study procedures. Both oncology and elderly (non-oncology) participants may be allocated to this arm. |
| Standard Perioperative Care | Active comparator | Other: Standard perioperative careParticipants receive standard perioperative care according to routine institutional practice without the coordinated RESET programme. Standard care may include selected supportive interventions if clinically indicated but does not include the structured multidisciplinary RESET pathway. Both oncology and elderly (non-oncology) participants may be allocated to this arm. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Age ≥ 18 years
- Qualification for admission to surgical departments with an ICD10 diagnosis for radical cancer surgery
- Preliminary qualification for one of the procedures listed in Section II.B.23
- Informed consent to participate in the study
- Informed consent to participate in the study
Key exclusion criteria (5 listed)
- Age < 18 years
- Qualification for admission to surgical departments with an ICD10 diagnosis for diagnostic procedures to identify cancer
- Pregnancy or breastfeeding
- NON-ONCOLOGY GROUP
- Diagnosis of cancer
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| RESET multimodal perioperative care pathwayRESET is a standardized, individualized, multidisciplinary perioperative care pathway delivered from approximately 21±7 days before surgery through 30-day follow-up. It includes: (1) preoperative assessment and personalized prehabilitation addressing nutrition, physical activity, psychological support, and medication optimization; (2) care coordination and communication with the prehabilitation team, supported by the RESET mobile application; (3) reassessment on hospital admission and coordinated perioperative planning; (4) enhanced recovery during hospitalization, including early mobilization, nutritional support, pain management, the SAFER Patient Flow Bundle, and Red-to-Green review; and (5) individualized discharge planning and transitional care. Components are tailored to the participant's clinical status, functional capacity, nutritional and psychological needs, comorbidities, and planned surgery. | Other | RESET Intervention |
| Standard perioperative careParticipants receive standard perioperative care according to routine practice at the participating hospital. This includes usual surgical and anesthetic qualification, preoperative tests and consultations when clinically indicated, routine inpatient surgical and postoperative care, discharge instructions, and standard follow-up. Participants do not receive the coordinated multidisciplinary RESET pathway or individualized RESET recommendations. Protocol-defined assessments and activity monitoring are performed in both study arms for research purposes and are not components of the comparator intervention. | Other | Standard Perioperative Care |
Primary outcome
Number of participants with prolonged index hospitalization lasting 14 calendar days or longer
Time frame: From the date of index hospital admission until the date of hospital discharge; prolonged hospitalization is determined when the index hospital stay reaches at least 14 calendar days, assessed up to 90 days after admission
Prolonged index hospitalization is defined as a hospital stay lasting 14 calendar days or longer, calculated from admission for the index surgical hospitalization to hospital discharge. The outcome will be reported as the number and percentage of participants meeting this definition in each study arm.
Number of participants with an unplanned hospital readmission within 30 days after index hospital discharge
Time frame: 30 days after index hospital discharge
An unplanned hospital readmission is defined as an unplanned admission to the same or another hospital within 30 days after discharge from the index hospitalization. Readmissions will be identified using hospital electronic health records, hospital information systems, and participant follow-up interviews. The outcome will be reported as the number and percentage of participants with at least one unplanned readmission.
Participants with at least one postoperative complication within 30 days after index surgery
Time frame: From completion of index surgery through postoperative day 30
Postoperative complications occurring after the index surgical procedure will be identified and graded according to the Clavien-Dindo classification. The outcome will be reported as the number and percentage of participants with at least one Clavien-Dindo grade I-V complication within 30 days after index surgery. For participants with multiple postoperative complications, the highest Clavien-Dindo grade observed during this period will also be recorded.
6 secondary outcomes
Length of index hospital stay in calendar days
Time frame: From the date of index hospital admission until the date of hospital discharge, assessed up to 90 days after admission
Change in overall health status
Time frame: Baseline at 21 ± 7 days before surgery, at index hospital admission before surgery following the preoperative intervention, and at 30 ± 5 days after hospital discharge
Patient satisfaction
Time frame: At the summary prehabilitation visit on the day 1 of hospital admission
Compliance with the prehabilitation protocol
Time frame: From the baseline prehabilitation visit, scheduled 21 ± 7 days before surgery, through hospital admission for surgery
Effectiveness of Stochastic Organizational Support Network Planning
Time frame: From the baseline prehabilitation visit, scheduled 21 ± 7 days before surgery, through hospital admission for surgery
Direct healthcare costs
Time frame: From the baseline prehabilitation visit through 30 days after discharge from the index hospitalization
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Jul 2026.
- Background: PubMed 40084835Wierzbicka M, Kiszka M, Barnas S, Jeziorny M, Zajac B, Dwornikowska-Dabrowska M, Jedruchniewicz N. The Ready for Safe Cancer Treatment (RESET) tool: enhancing quality and optimizing timely and safe discharge with transitional care adjustments for Head and Neck Cancer patients. Otolaryngol Pol. 2025 Mar 14;79(3):1-7. doi: 10.5604/01.3001.0055.0006.
- Individual participant dataSharing planned: Yes. De-identified individual participant data underlying the results reported in study publications will be made available upon reasonable request to the Principal Investigator. Shared data may include the participant-level analysis dataset and the associated data dictionary. Supporting materials may include the full study protocol and statistical code. Data sharing will be subject to compliance with participant consent, applicable data-protection requirements, institutional requirements, and approval of the proposed use by the Sponsor and Principal Investigator.
Related trials for Neoplasms
RecruitingPhase 2
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Not yet recruiting
Effect of a Health Belief Model Based Digital Nudge Intervention on Breast Cancer Screening
Breast Cancer Screening, Breast Cancer Awareness
Not yet recruiting
The AYA Oncology Self-care Movement
Acute Lymphobkastic Leukemia, Medication Adherence
Not yet recruitingPhase 1/2
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
Thyroid Cancer
RecruitingPhase 2
The COSMYC Trial (COmbined Suppression of MYC)
Metastatic Castration-resistant Prostate Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Małgorzata Wierzbicka, Professor principal investigator
Regional Specialist Hospital in Wroclaw
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing RESET multimodal perioperative care pathway and Standard perioperative care in people with Neoplasms and Frailty, run by Regional Specialist Hospital in Wroclaw at 2 sites in Poland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 27 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Natalia Jędruchniewicz, PhD (+48713270538, natalia.jedruchniewicz@wssk.wroc.pl), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of participants with prolonged index hospitalization lasting 14 calendar days or longer (time frame: From the date of index hospital admission until the date of hospital discharge; prolonged hospitalization is determined when the index hospital stay reaches at least 14 calendar days, assessed up to 90 days after admission). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07727876, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2026.